Home › Funds › Parkman Healthcare Partners LLC › IQV
Parkman Healthcare Partners LLC position in IQV
IQVIA HLDGS INC · Health Care
Parkman Healthcare Partners LLC reported holding 145,221 shares of IQV (IQVIA HLDGS INC) in its Q3 2026 13F filing — a position valued at US$39.0M, representing 3.52% of its reported portfolio and ranking #4 among its reported holdings. Parkman Healthcare Partners LLC has disclosed IQV holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Parkman Healthcare Partners LLC's IQV position evolved
Parkman Healthcare Partners LLC first disclosed a stake in IQV in Q2 2025 at 109,500 shares (US$17.3M). The position peaked in Q3 2026 at 145,221 shares, worth US$39.0M. Across 6 filings, Parkman Healthcare Partners LLC increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 145,221 shares valued at US$39.0M — an increase of 39,410 shares quarter over quarter.. Notable position changes include a 73% trim in Q3 2025 (shares rose 19% over the following quarter), a 146% increase in Q1 2026 (shares rose 13% over the following quarter), a 37% increase in Q3 2026 (shares fell 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 109.50K | $17.26M | New |
| Q3 2025 | 30.00K | $5.70M | Reduce |
| Q4 2025 | 35.23K | $7.94M | Add |
| Q1 2026 | 86.70K | $14.79M | Add |
| Q2 2026 | 105.81K | $20.44M | Add |
| Q3 2026 | 145.22K | $39.04M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IQV and 13F data
IQV (IQVIA HLDGS INC) is a Health Care company. 28 other funds we track also report a position in IQV — the largest reported positions include Harris Associates (Oakmark) (US$2.35B), HARRIS ASSOCIATES L P (US$2.35B), Boston Partners (US$1.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IQV
- Harris Associates (Oakmark) 12.18M sh · $2.35B · Q2 2026
- HARRIS ASSOCIATES L P 12.18M sh · $2.35B · Q2 2026
- Boston Partners 4.37M sh · $1.17B · Q3 2026
- Artisan Partners Limited Partnership 3.46M sh · $930.59M · Q3 2026
- WCM INVESTMENT MANAGEMENT, LLC 2.67M sh · $717.70M · Q3 2026
- Longview Partners (Guernsey) LTD 1.26M sh · $337.79M · Q3 2026
- LYRICAL ASSET MANAGEMENT LP 1.25M sh · $337.08M · Q3 2026
- Orbis Allan Gray Ltd 1.16M sh · $312.20M · Q3 2026
More on Parkman Healthcare Partners LLC
FAQ
How long has Parkman Healthcare Partners LLC held IQV?
Parkman Healthcare Partners LLC has disclosed IQV holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Parkman Healthcare Partners LLC's current position in IQV?
As of Q3 2026, Parkman Healthcare Partners LLC holds 145.22K shares of IQV (IQVIA HLDGS INC), valued at $39.04M, representing 3.52% of its reported portfolio and ranking #4.
Has Parkman Healthcare Partners LLC been buying or selling IQV?
In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC increased its position in IQV. The position peaked in Q3 2026 at 145.22K shares.
Which other funds hold IQV?
Other major institutional holders of IQV include Harris Associates (Oakmark), HARRIS ASSOCIATES L P, Boston Partners, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.